Literature DB >> 24941315

Prescription medication use by Canadians aged 6 to 79.

Michelle Rotermann1, Claudia Sanmartin1, Deirdre Hennessy2, Michele Arthur3.   

Abstract

Based on data from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey, this article provides national information about prescription medication use among community-dwelling Canadians. An estimated 41% of 6- to 79-year-olds who lived in private households reported taking at least one prescription medication in the past two days (current use). Generally, prescription drug use was higher among females and among people in poorer health, and increased with age. Approximately 11% of 45- to 64-year-olds and 30% of seniors aged 65 to 79 took at least five prescription medications concurrently. For adults aged 25 to 79, the leading prescription medication classes were lipid-lowering agents, ACE-inhibitors, peptic-ulcer and acid-reducers, beta-blockers (men), other analgesics and anti-pyretics (men), anti-depressants (women) and thyroid medication (women). Among children and young adults aged 6 to 24, the leading prescription medications were for attention deficit and hyperactivity disorder (males), depression, and hormonal contraception (females).

Entities:  

Keywords:  Chronic conditions; drug therapy; polypharmacy

Mesh:

Substances:

Year:  2014        PMID: 24941315

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  35 in total

1.  Why is depression more prevalent in women?

Authors:  Paul R Albert
Journal:  J Psychiatry Neurosci       Date:  2015-07       Impact factor: 6.186

2.  Cardiac Sudden Death in Psychiatric Patients.

Authors:  Hiroyuki Uchida; Takefumi Suzuki
Journal:  Can J Psychiatry       Date:  2015-05       Impact factor: 4.356

3.  Are selective serotonin reuptake inhibitors associated with fractures?

Authors:  Sarah Drost; Anne Massicotte
Journal:  Can Pharm J (Ott)       Date:  2016-10-06

4.  Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study.

Authors:  Martin Dawes; Martin N Aloise; J Sidney Ang; Pieter Cullis; Diana Dawes; Robert Fraser; Gideon Liknaitzky; Andrea Paterson; Paul Stanley; Adriana Suarez-Gonzalez; Hagit Katzov-Eckert
Journal:  CMAJ Open       Date:  2016-09-21

5.  Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.

Authors:  Tu N Nguyen; Patrice Ngangue; Jeannie Haggerty; Tarek Bouhali; Martin Fortin
Journal:  Fam Pract       Date:  2019-11-18       Impact factor: 2.267

6.  Antidepressant and antipsychotic prescribing in primary care for people with dementia.

Authors:  Neil Drummond; Lynn McCleary; Elizabeth Freiheit; Frank Molnar; William Dalziel; Carole Cohen; Diana Turner; Rebecca Miyagishima; James Silvius
Journal:  Can Fam Physician       Date:  2018-11       Impact factor: 3.275

Review 7.  Variation of the prevalence of pediatric polypharmacy: A scoping review.

Authors:  Courtney Baker; James A Feinstein; Xuan Ma; Shari Bolen; Neal V Dawson; Negar Golchin; Alexis Horace; Lawrence C Kleinman; Sharon B Meropol; Elia M Pestana Knight; Almut G Winterstein; Paul M Bakaki
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-02-06       Impact factor: 2.890

Review 8.  Pharmacogenomic Testing for Psychotropic Medication Selection: A Systematic Review of the Assurex GeneSight Psychotropic Test.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-04-11

9.  An examination of three prescribing cascades in a cohort of older adults with dementia.

Authors:  Shanna C Trenaman; Susan K Bowles; Susan Kirkland; Melissa K Andrew
Journal:  BMC Geriatr       Date:  2021-05-08       Impact factor: 3.921

10.  Analyses of Child and Youth Self-Poisoning Hospitalizations by Substance and Socioeconomic Status.

Authors:  Samantha Pawer; Fahra Rajabali; Alex Zheng; Jennifer Smith; Roy Purssell; Ian Pike
Journal:  Int J Environ Res Public Health       Date:  2021-06-30       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.